• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体结合诱导的酵母和鼠蛋白酶体核心颗粒的差异全局结构变化。

Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding.

机构信息

Emeritus Group Structure Research, Max Planck Institut für Biochemie, 82152 Martinsried, Germany;Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Unversität München, 85748 Garching, Germany;

Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Unversität München, 85748 Garching, Germany;

出版信息

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9479-84. doi: 10.1073/pnas.1408018111. Epub 2014 Jun 16.

DOI:10.1073/pnas.1408018111
PMID:24979800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4084421/
Abstract

Two clusters of configurations of the main proteolytic subunit β5 were identified by principal component analysis of crystal structures of the yeast proteasome core particle (yCP). The apo-cluster encompasses unliganded species and complexes with nonpeptidic ligands, and the pep-cluster comprises complexes with peptidic ligands. The murine constitutive CP structures conform to the yeast system, with the apo-form settled in the apo-cluster and the PR-957 (a peptidic ligand) complex in the pep-cluster. In striking contrast, the murine immune CP classifies into the pep-cluster in both the apo and the PR-957-liganded species. The two clusters differ essentially by multiple small structural changes and a domain motion enabling enclosure of the peptidic ligand and formation of specific hydrogen bonds in the pep-cluster. The immune CP species is in optimal peptide binding configuration also in its apo form. This favors productive ligand binding and may help to explain the generally increased functional activity of the immunoproteasome. Molecular dynamics simulations of the representative murine species are consistent with the experimentally observed configurations. A comparison of all 28 subunits of the unliganded species with the peptidic liganded forms demonstrates a greatly enhanced plasticity of β5 and suggests specific signaling pathways to other subunits.

摘要

通过对酵母蛋白酶体核心颗粒(yCP)晶体结构的主成分分析,鉴定出主要蛋白酶体亚基β5 的两个结构簇。无配体簇包含未配位的物种和与非肽配体的复合物,而肽簇则包含与肽配体的复合物。鼠源组成型 CP 结构与酵母系统一致,apo 形式位于 apo 簇中,PR-957(一种肽配体)复合物位于 pep 簇中。相比之下,鼠源免疫 CP 在 apo 和 PR-957 配体物种中均归类于 pep 簇。这两个结构簇主要通过多种小的结构变化和结构域运动来区分,这些变化使肽配体得以封闭,并在 pep 簇中形成特定的氢键。免疫 CP 物种在 apo 形式下也处于最佳的肽结合构象。这有利于有效配体结合,并可能有助于解释免疫蛋白酶体通常增加的功能活性。代表性鼠源的分子动力学模拟与实验观察到的结构一致。将无配体物种的所有 28 个亚基与肽配体形式进行比较,表明β5 的可塑性大大增强,并暗示存在特定的信号转导途径到其他亚基。

相似文献

1
Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding.配体结合诱导的酵母和鼠蛋白酶体核心颗粒的差异全局结构变化。
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9479-84. doi: 10.1073/pnas.1408018111. Epub 2014 Jun 16.
2
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.新型非共价蛋白酶体抑制剂的特性研究,该抑制剂对 20Sβ5 亚基具有极高的活性和选择性。
Biochem J. 2010 Sep 15;430(3):461-76. doi: 10.1042/BJ20100383.
3
Crystal structure of the human 20S proteasome in complex with carfilzomib.人20S蛋白酶体与卡非佐米复合物的晶体结构
Structure. 2015 Feb 3;23(2):418-24. doi: 10.1016/j.str.2014.11.017. Epub 2015 Jan 15.
4
Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome.N,C-封端二肽与结核分枝杆菌蛋白酶体的物种选择性结合的结构基础
Biochemistry. 2017 Jan 10;56(1):324-333. doi: 10.1021/acs.biochem.6b01107. Epub 2016 Dec 27.
5
Structural biology of the proteasome.蛋白酶体的结构生物学。
Annu Rev Biophys. 2013;42:29-49. doi: 10.1146/annurev-biophys-083012-130417. Epub 2013 Feb 13.
6
Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome.探究水解位点远端的结构决定因素,这些因素控制着20S蛋白酶体的底物特异性。
Chem Biol. 2002 May;9(5):655-62. doi: 10.1016/s1074-5521(02)00144-8.
7
Bortezomib-resistant mutant proteasomes: structural and biochemical evaluation with carfilzomib and ONX 0914.硼替佐米耐药突变蛋白酶体:用卡非佐米和ONX 0914进行的结构与生化评估
Structure. 2015 Feb 3;23(2):407-17. doi: 10.1016/j.str.2014.11.019. Epub 2015 Jan 15.
8
Structure of the human 26S proteasome: subunit radial displacements open the gate into the proteolytic core.人类26S蛋白酶体的结构:亚基的径向位移打开通往蛋白水解核心的通道。
J Biol Chem. 2008 Aug 22;283(34):23305-14. doi: 10.1074/jbc.M802716200. Epub 2008 Jun 5.
9
Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.通过药效团筛选、共价对接和分子动力学模拟相结合的方法发现新型共价蛋白酶体抑制剂。
J Mol Model. 2014 Nov;20(11):2515. doi: 10.1007/s00894-014-2515-y. Epub 2014 Nov 14.
10
The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10.20S 免疫蛋白酶体和组成型蛋白酶体与 PA28αβ 的结合亲和力相同,并同样降解 FAT10。
Mol Immunol. 2019 Sep;113:22-30. doi: 10.1016/j.molimm.2017.11.030. Epub 2017 Dec 6.

引用本文的文献

1
Structural basis for allosteric modulation of M. tuberculosis proteasome core particle.结核分枝杆菌蛋白酶体核心颗粒变构调节的结构基础
Nat Commun. 2025 Apr 1;16(1):3138. doi: 10.1038/s41467-025-58430-0.
2
Mechanistic diversity in MHC class I antigen recognition.MHC I 类抗原识别中的机制多样性。
Biochem J. 2021 Dec 22;478(24):4187-4202. doi: 10.1042/BCJ20200910.
3
Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks.人类 20S 蛋白酶体的构象图谱揭示了 PA28-和免疫依赖性的环间串扰。
Nat Commun. 2020 Dec 1;11(1):6140. doi: 10.1038/s41467-020-19934-z.
4
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis.解析多发性硬化症中细胞外蛋白酶体-骨桥蛋白循环动力学。
Cells. 2019 Mar 20;8(3):262. doi: 10.3390/cells8030262.
5
Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.人免疫蛋白酶体的结构与一种可逆的非竞争性抑制剂结合,该抑制剂选择性抑制活化的淋巴细胞。
Nat Commun. 2017 Nov 22;8(1):1692. doi: 10.1038/s41467-017-01760-5.
6
A widespread family of serine/threonine protein phosphatases shares a common regulatory switch with proteasomal proteases.广泛存在的丝氨酸/苏氨酸蛋白磷酸酶家族与蛋白酶体蛋白酶共享一个共同的调节开关。
Elife. 2017 May 20;6:e26111. doi: 10.7554/eLife.26111.
7
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.细胞外蛋白酶体-骨桥蛋白循环调节细胞迁移,这对多发性硬化症有影响。
Sci Rep. 2017 Mar 9;7:43718. doi: 10.1038/srep43718.
8
Understanding the molecular mechanism for the differential inhibitory activities of compounds against MTH1.了解化合物对 MTH1 抑制活性差异的分子机制。
Sci Rep. 2017 Jan 11;7:40557. doi: 10.1038/srep40557.
9
Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism.前蛋白转化酶弗林蛋白酶无配体形式的结构表明其通过底物诱导机制被激活。
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11196-11201. doi: 10.1073/pnas.1613630113. Epub 2016 Sep 19.
10
Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.蛋白酶体活性的抑制诱导替代蛋白酶体复合物的形成。
J Biol Chem. 2016 Jun 17;291(25):13147-59. doi: 10.1074/jbc.M116.717652. Epub 2016 Apr 18.

本文引用的文献

1
Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.发现 PI-1840,一种新型的非共价和快速可逆的蛋白酶体抑制剂,具有抗肿瘤活性。
J Biol Chem. 2014 Apr 25;289(17):11906-11915. doi: 10.1074/jbc.M113.533950. Epub 2014 Feb 25.
2
Tracing an allosteric pathway regulating the activity of the HslV protease.追踪调节 HslV 蛋白酶活性的别构途径。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2140-5. doi: 10.1073/pnas.1318476111. Epub 2014 Jan 27.
3
Principal component analysis: a method for determining the essential dynamics of proteins.主成分分析:一种确定蛋白质基本动力学的方法。
Methods Mol Biol. 2014;1084:193-226. doi: 10.1007/978-1-62703-658-0_11.
4
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.GROMACS 4.5:一个高吞吐量、高度并行的开源分子模拟工具包。
Bioinformatics. 2013 Apr 1;29(7):845-54. doi: 10.1093/bioinformatics/btt055. Epub 2013 Feb 13.
5
Proteasome allostery as a population shift between interchanging conformers.蛋白酶体变构作为构象交换之间的群体转变。
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3454-62. doi: 10.1073/pnas.1213640109. Epub 2012 Nov 12.
6
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity.免疫和组成型蛋白酶体晶体结构揭示了底物和抑制剂特异性的差异。
Cell. 2012 Feb 17;148(4):727-38. doi: 10.1016/j.cell.2011.12.030.
7
Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme.免疫蛋白酶体在先天免疫和适应性免疫反应的界面:一种酶的两面。
Curr Opin Immunol. 2012 Feb;24(1):77-83. doi: 10.1016/j.coi.2012.01.005. Epub 2012 Jan 31.
8
Principal component and normal mode analysis of proteins; a quantitative comparison using the GroEL subunit.蛋白质的主成分和正则模态分析;使用 GroEL 亚基进行的定量比较。
Proteins. 2011 Jan;79(1):232-43. doi: 10.1002/prot.22875.
9
Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.免疫蛋白酶体在干扰素诱导的氧化应激下维持蛋白质平衡。
Cell. 2010 Aug 20;142(4):613-24. doi: 10.1016/j.cell.2010.07.036.
10
The 26S proteasome: assembly and function of a destructive machine.26S 蛋白酶体:破坏机器的组装和功能。
Trends Biochem Sci. 2010 Nov;35(11):634-42. doi: 10.1016/j.tibs.2010.05.005. Epub 2010 Jun 10.